Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Boston Scientific Corp (BSX)  
$71.87 0.63 (0.87%) as of 4:30 Tue 4/30


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 1,430,000,000
Market Cap: 102.77(B)
Last Volume: 8,713,116 Avg Vol: 8,469,733
52 Week Range: $48.64 - $73.26
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:

    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  297
Guru Rank Value     : 4.1
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 96,581 377,614 901,711 1,862,313
Total Sell Value $6,534,949 $22,111,166 $49,794,655 $91,194,728
Total People Sold 6 8 11 13
Total Sell Transactions 10 20 37 70
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 2518
  Page 5 of 101  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Fitzgerald Joseph Michael EVP & Group Pres, Cardiology   •       •      –    2024-02-12 4 GA $0.00 $0 I/I 550 4,894     -
   Fitzgerald Joseph Michael EVP & Group Pres, Cardiology   •       •      –    2024-02-12 4 GD $0.00 $0 D/D 6,000 184,354     -
   Butcher Arthur C EVP& Grp Pres, MedSurg & APAC   •       •      –    2024-02-06 4 D $0.00 $0 D/D (9,722) 28,011     -
   Butcher Arthur C EVP& Grp Pres, MedSurg & APAC   •       •      –    2024-02-06 4 A $0.00 $0 D/D 22,666 37,733     -
   Carruthers Wendy EVP, Human Resources   •       •      –    2024-02-06 4 D $0.00 $0 D/D (7,983) 57,678     -
   Carruthers Wendy EVP, Human Resources   •       •      –    2024-02-06 4 A $0.00 $0 D/D 18,000 65,661     -
   Sorenson John Bradley EVP, Global Operations   •       •      –    2024-02-06 4 D $0.00 $0 D/D (5,472) 47,336     -
   Sorenson John Bradley EVP, Global Operations   •       •      –    2024-02-06 4 A $0.00 $0 D/D 12,000 52,808     -
   Fitzgerald Joseph Michael EVP & Group Pres, Cardiology   •       •      –    2024-02-06 4 D $0.00 $0 D/D (16,450) 190,354     -
   Fitzgerald Joseph Michael EVP & Group Pres, Cardiology   •       •      –    2024-02-06 4 A $0.00 $0 D/D 33,332 206,804     -
   Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr   •       •      –    2024-02-06 4 D $0.00 $0 D/D (11,579) 26,197     -
   Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr   •       •      –    2024-02-06 4 A $0.00 $0 D/D 20,000 37,776     -
   Mahoney Michael F Chairman, President & CEO   •       •      –    2024-02-06 4 D $0.00 $0 D/D (65,047) 1,636,356     -
   Mahoney Michael F Chairman, President & CEO   •       •      –    2024-02-06 4 A $0.00 $0 D/D 146,666 1,701,403     -
   Mirviss Jeffrey B. EVP&Pres, Periph Intervent   •       •      –    2024-02-06 4 D $0.00 $0 D/D (12,160) 71,094     -
   Mirviss Jeffrey B. EVP&Pres, Periph Intervent   •       •      –    2024-02-06 4 A $0.00 $0 D/D 26,666 83,254     -
   Brennan Daniel J. EVP and CFO   •       •      –    2024-02-06 4 D $0.00 $0 D/D (16,262) 262,142     -
   Brennan Daniel J. EVP and CFO   •       •      –    2024-02-06 4 A $0.00 $0 D/D 36,666 278,404     -
   Fitzgerald Joseph Michael EVP & Group Pres, Cardiology   •       •      –    2024-01-12 4 AS $60.00 $699,600 D/D (11,660) 173,472 22%     
   Mirviss Jeffrey B. EVP&Pres, Periph Intervent   •       •      –    2024-01-09 4 AS $59.25 $898,941 D/D (15,172) 56,588 24%     
   Mirviss Jeffrey B. EVP&Pres, Periph Intervent   •       •      –    2024-01-09 4 OE $16.31 $247,455 D/D 15,172 71,760     -
   Mirviss Jeffrey B. EVP&Pres, Periph Intervent   •       •      –    2024-01-04 4 AS $58.40 $876,002 D/D (15,000) 56,588 26%     
   Mirviss Jeffrey B. EVP&Pres, Periph Intervent   •       •      –    2024-01-04 4 OE $16.31 $244,650 D/D 15,000 71,588     -
   Mirviss Jeffrey B. EVP&Pres, Periph Intervent   •       •      –    2024-01-03 4 AS $57.82 $689,862 D/D (11,931) 56,588 27%     
   Mirviss Jeffrey B. EVP&Pres, Periph Intervent   •       •      –    2024-01-01 4 D $57.81 $318,417 D/D (5,508) 68,519     -

  2518 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 101
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed